MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Stock Quote
- Sector Info (pharmaceuticals)
- Indian Pharma
Indian Pharma Stocks 
Here are the latest stock price details of India's top Indian Pharma stocks. For more detailed updates, read our Indian Pharma sector report and check the latest Indian Pharma sector results.
| SCRIP | BSE PRICE (Rs) | NSE PRICE (Rs) | CHART | MORE INFO |
|---|---|---|---|---|
| AARTI DRUGS | 600.00 -1.13% | 603.80 -0.76% | More Info
|
|
| AJANTA PHARMA | 1,132.00 -1.86% | 1,135.95 -1.35% | More Info
|
|
| ALEMBIC PHARMA | 590.05 -0.40% | 590.00 -0.24% | More Info
|
|
| BIOCON LTD | 670.90 2.06% | 670.70 1.98% | More Info
|
|
| CADILA HEALTHCARE | 345.40 -2.96% | 345.00 -3.05% | More Info
|
|
| CIPLA | 509.15 -0.12% | 509.15 -0.09% | More Info
|
|
| DIVIS LABORATORIES | 1,499.35 -0.33% | 1,503.65 -0.11% | More Info
|
|
| GLENMARK PHARMA | 640.35 -3.15% | 640.00 -3.25% | More Info
|
|
| INDOCO REMEDIES | 210.85 -2.02% | 209.35 -3.26% | More Info
|
|
| IPCA LABS | 768.00 -2.41% | 767.20 -2.63% | More Info
|
|
| J.B.CHEMICALS | 317.90 0.06% | 321.00 1.69% | More Info
|
|
| LUPIN LTD | 858.70 -1.11% | 860.00 -1.01% | More Info
|
|
| NATCO PHARMA | 686.95 -0.82% | 689.55 -0.01% | More Info
|
|
| NIFTY 50 | Not Listed | 10,870.50 -0.32% | More Info
|
|
| ORCHID PHARMA LTD | 4.84 0.62% | 18.90 -2.83% | More Info
|
|
| PANACEA BIOTECH | 173.55 -4.33% | 172.90 -4.37% | More Info
|
|
| PIRAMAL ENTERPRISES | 2,334.00 -2.21% | 2,335.30 -2.20% | More Info
|
|
| S&P BSE SENSEX | 36,262.28 -0.31% | Not Listed | More Info
|
|
| STRIDES PHARMA SCIENCE | 506.85 -4.07% | 508.95 -3.68% | More Info
|
|
| SUN PHARMA | 383.45 -10.23% | 382.45 -10.34% | More Info
|
|
| TORRENT PHARMA | 1,913.00 1.36% | 1,915.60 1.57% | More Info
|
|
| WOCKHARDT LTD. | 492.00 -1.86% | 492.90 -1.68% | More Info
|
BSE prices: January 18, 2019 10:43:00 AM NSE prices: January 18, 2019 10:44:59 AM
Indian Pharma Stocks Update
The NIFTY PHARMA Index is currently trading at 8,676.8 (down 2.8%). The index is down 15.8% over the last 30 days. And over the last 1 year, it has lost 7.6%.
Within the Indian Pharma sector, the top gainers are BIOCON LTD (up 2.1%) and TORRENT PHARMA (up 1.4%). On the other hand, SUN PHARMA (down 10.2%) and PANACEA BIOTECH (down 4.3%) are among the top losers.
Meanwhile, the benchmark NIFTY 50 is at 10,870.5 (down 0.3%).
|
| |
Today's Market
Sensex Opens Flat; Sun Pharma Falls Over 9.2%(09:30 am)
Asian stock markets are higher today as Chinese and Hong Kong shares show gains. The Shanghai Composite is up 0.6% while the Hang Seng is up 1%.
Related Views on News
SUN PHARMA Plunges by 10%; BSE HEALTHCARE Index Down 1.8% (Market Updates)
Jan 18, 2019 | Updated on Jan 18, 2019SUN PHARMA share price has plunged by 10% and its current market price is Rs 426. The BSE HEALTHCARE is down by 1.8%. The top gainers in the BSE HEALTHCARE Index are CAPLIN POINT (up 1.7%) and ABBOTT INDIA (up 0.9%). The top losers is SUN PHARMA (down 10.1%)..
SUN PHARMA Plunges by 10%; BSE HEALTHCARE Index Down 1.6% (Market Updates)
Jan 18, 2019 | Updated on Jan 18, 2019SUN PHARMA share price has plunged by 10% and its current market price is Rs 426. The BSE HEALTHCARE is down by 1.6%. The top gainers in the BSE HEALTHCARE Index are NATCO PHARMA (up 1.9%) and SYNGENE INTERNATIONAL (up 1.6%). The top losers is SUN PHARMA (down 10.0%)..
DIVIS LABORATORIES 2017-18 Annual Report Analysis (Annual Result Update)
Jan 1, 2019 | Updated on Jan 1, 2019Here's an analysis of the annual report of DIVIS LABORATORIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.
Aster DM Healthcare (IPO)
Feb 10, 2018Should you subscribe to the IPO of Aster DM Healthcare Ltd?
Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)
Feb 9, 2018US business was hit by pricing pressure although there was growth sequentially led by new product launches.
More Views on NewsMost Popular
Our First Bluechip Stock Recommendation in Smart Money Secrets(The 5 Minute Wrapup)
Jan 9, 2019For the first time, we have recommended a bluechip stock in Smart Money Secrets.
3 Stocks in Super Investor Sumeet Nagar's Portfolio That You Can Buy Right Now(The 5 Minute Wrapup)
Jan 11, 2019The reasons that make these six stocks in Sumeet Nagar's portfolio so compelling
The Biggest Trend That I'm Seeing in the Market Today(The 5 Minute Wrapup)
Jan 10, 2019For the first time ever, a majority of Indian households, will start to benefit from stock market wealth.
My First Stock Trading Recommendation For 2019(Profit Hunter)
Jan 10, 2019My first trading recommendation for 2019 is a bluechip auto stock. Find out everything about it right away.
A Proven Super Investor Can Lead to Great Wealth(Profit Hunter)
Jan 7, 2019Following a super investor can certainly help build a portfolio that can create significant wealth in the long term.
More|
| |
S&P BSE HEALTHCARE
Jan 18, 2019 10:43 AM
S&P BSE HEALTHCARE 5-YR ANALYSIS
COMPARE COMPANY
OTHER USEFUL LINKS
MARKET STATS
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
APPS
FOLLOW
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.